Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

874 ARTÍCULOS , VIENDO DEL 526 AL 540

Parkinson Disease

Rawls A, Okun MS.

Continuum (Minneap Minn). 2025 Aug;31(4):930-955. doi: 10.1212/cont.0000000000001593. Epub 2025 Aug 1.

Deep brain stimulation surgical timing, outcomes, and prognostic factors in patients with Parkinson's disease: A Chinese retrospective multicenter cohort study

Wang S, Hu W, Gao Y, Wang A, Chen L, Liang Z, Zhang S, Long H, Li W, Niu C, Liu W, Cai G, Ji Y, Tam J, Xu Q, Yang A, Shi L, Zhang H, Han C, Zhu G, Bai Y, Jiang L, Li T, Xue S, Wang H, Li Y, Xiong C, Lozano AM, Ramirez-Zamora A, Zhang W, Meng F, Zhang J; DBS-PDCC2 Collaboration.

PLoS Med. 2025 Aug 1;22(8):e1004670. doi: 10.1371/journal.pmed.1004670. eCollection 2025 Aug.

Efficacy and safety of oral amantadine in Parkinson's disease with dyskinesia and motor fluctuations: a systematic review and meta-analysis of randomised controlled trials

Rujirussawarawong S, Aungsumart S, Kasemsuk C, Limotai N.

BMJ Neurol Open. 2025 Jun 15;7(1):e001115. doi: 10.1136/bmjno-2025-001115. eCollection 2025.

Spinal cord stimulation restores locomotion in a Parkinson's disease patient and rodents

Slack JC, Rees B, Borda E, Slack J, Nicolelis MAL, Zauber SE, Gupta K, Yadav AP.

Brain Stimul. 2025 Sep-Oct;18(5):1407-1422. doi: 10.1016/j.brs.2025.07.020. Epub 2025 Aug 5.

Validation of the Polish version of the Movement Disorder Society Non-motor Rating Scale (MDS-NMS)

Siuda J, Toś M, Chmiela T, Bogucki A, Borodziuk B, Budrewicz S, Dąbrowski M, Gacan M, Gajos A, Gawryluk J, Janik P, Kaczyńska J, Koziorowska-Gawron E, Malkiewicz J, Papuć E, Kaczmarska P, Rudzińska-Bar M, Sławek J, Wójcik-Pędziwiatr M, Yu L, Luo S, Goetz C, Stebbins G, Martinez-Martin P, Mestre T, Sanchez-Ferro A, Kurtis M, Hyczy de Siqueira Tosin M, Balestrino R, Lin CR, Gasca-Salas C.

Neurol Neurochir Pol. 2025;59(4):396-402. doi: 10.5603/pjnns.105278. Epub 2025 Aug 6.

Recent advances in cell membrane-based biomimetic delivery systems for Parkinson's disease: Perspectives and challenges

Kaur J, Thakran A, Naqvi S.

Asian J Pharm Sci. 2025 Aug;20(4):101060. doi: 10.1016/j.ajps.2025.101060. Epub 2025 Apr 21.

CDS-PD: A Novel Clinical Decision Support Platform for Parkinson's Disease

Gupta DK, Golnari P, Prantzalos K, Zurlo I, Iyer V, Lobb BM, Zweber C, Bulusu M, Clarke D, Boyd JT, Tatsuoka C, Hiller AL, Sahoo SS.

medRxiv [Preprint]. 2025 Jul 25:2025.07.24.25331875. doi: 10.1101/2025.07.24.25331875.

Restless legs syndrome in Parkinson's disease: epidemiology, pathogenetic overlaps, and clinical management

Wang Z, Zhang S, Li J, Liu H, Hu X, Yu Q, Kuang G, Liu L, Zhang H, Yu D, Xiong N.

J Neurol. 2025 Aug 11;272(9):567. doi: 10.1007/s00415-025-13288-6.

Anti-Neuroinflammatory and Anti-Inflammatory Effects of the NLRP3 Inhibitor NT-0796 in Subjects with Parkinson's Disease

Clarke N, Thornton P, Reader V, Lindsay N, Digby Z, Mullen B, Gorman M, Jacobson E, Langdon G, Johnstone H, Wheeler A, Watt AP.

Mov Disord. 2025 Oct;40(10):2199-2208. doi: 10.1002/mds.30307. Epub 2025 Aug 12.

Robotic arm vs. stereotactic frame in deep brain stimulation surgery for movement disorders: a retrospective cohort study

Perera D, Ramos PR, Valldeoriola F, Sánchez-Gómez A, Ferrés A, Pérez-Baldioceda C, Cabrera G, Mosteiro A, Gómez L, Codes M, Manfrellotti R, Rumià J.

Acta Neurochir (Wien). 2025 Aug 12;167(1):219. doi: 10.1007/s00701-025-06618-0.

Surprises From the Basal Ganglia: Stop and Go Have New Meaning

Graybiel AM.

Mov Disord. 2025 Oct;40(10):2077-2082. doi: 10.1002/mds.70008. Epub 2025 Aug 14.

One Side or Two? A Systematic Review of Deep Brain Stimulation Approaches in Movement Disorders

Vetkas A, Yang A, Boutet A, Cheyuo C, Santyr B, Sarica C, Davidson B, Fomenko A, Samuel N, Lang S, Sumarac S, Milosevic L, Valiante T, Hodaie M, Kalia SK, Lozano AM.

Mov Disord Clin Pract. 2025 Dec;12(12):2080-2091. doi: 10.1002/mdc3.70274. Epub 2025 Aug 14.

Epigenetic Mediating Mechanisms in Parkinson's Disease: The Impact of Educational Attainment on SETD1A Expression

Yin KF, Gu XJ, Yu JM, Su WM, Yang WJ, Duan QQ, He SY, Shen C, Lu SJ, Chi LY, Wang Y, Cao B, Chen YP.

Mov Disord. 2025 Nov;40(11):2431-2444. doi: 10.1002/mds.70010. Epub 2025 Aug 19.

Acupuncture modulates the microbiota-gut-brain axis: a new strategy for Parkinson's disease treatment

Zang Z, Yang F, Qu L, Ge M, Tong L, Xue L, Sun X, Hai Y.

Front Aging Neurosci. 2025 Aug 7;17:1640389. doi: 10.3389/fnagi.2025.1640389. eCollection 2025.

Current Status of α-Synuclein Biomarkers and the Need for α-Synuclein PET Tracers

Berman SE, Siderowf AD.

Cells. 2025 Aug 18;14(16):1272. doi: 10.3390/cells14161272.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias